397 related articles for article (PubMed ID: 20724773)
1. Testosterone replacement therapy in prostate cancer patients: is it safe?
Umbas R; Sugiono M
Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
[TBL] [Abstract][Full Text] [Related]
2. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
Algarté-Génin M; Cussenot O; Costa P
Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
[TBL] [Abstract][Full Text] [Related]
3. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
5. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
6. The role of testosterone replacement therapy following radical prostatectomy.
Khera M; Lipshultz LI
Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
[TBL] [Abstract][Full Text] [Related]
7. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
8. Androgen deficiency in aging and metabolically challenged men.
Shelton JB; Rajfer J
Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
[TBL] [Abstract][Full Text] [Related]
9. Testosterone replacement therapy after primary treatment for prostate cancer.
Agarwal PK; Oefelein MG
J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
11. The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism.
Volpato S; Vigna GB; Fellin R
Acta Biomed; 2010; 81 Suppl 1():95-9. PubMed ID: 20518198
[TBL] [Abstract][Full Text] [Related]
12. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
Ebert T; Jockenhövel F; Morales A; Shabsigh R
Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
Barqawi A; Crawford ED
Int J Impot Res; 2006; 18(4):323-8. PubMed ID: 16281043
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and the aging male: to treat or not to treat?
Bain J
Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Gould DC; Kirby RS
Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
[TBL] [Abstract][Full Text] [Related]
17. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
Raynor MC; Carson CC; Pearson MD; Nix JW
Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in the ageing male: what about the prostate?
Schultheiss D; Machtens S; Jonas U
Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
[TBL] [Abstract][Full Text] [Related]
19. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
20. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
Kaufman J
Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]